Cargando…
Very Late Pathological Responses to Cobalt–Chromium Everolimus‐Eluting, Stainless Steel Sirolimus‐Eluting, and Cobalt–Chromium Bare Metal Stents in Humans
BACKGROUND: The “very late” clinical outcomes for durable polymer drug‐eluting stents and bare metal stents (BMSs) have been shown to be dissimilar in clinical studies. Conceptually, the long‐term vascular compatibility of BMSs is still regarded to be superior to drug‐eluting stents; however, no pat...
Autores principales: | Mori, Hiroyoshi, Atmakuri, Dheeraj R., Torii, Sho, Braumann, Ryan, Smith, Samantha, Jinnouchi, Hiroyuki, Gupta, Anuj, Harari, Emanuel, Shkullaku, Melsi, Kutys, Robert, Fowler, David, Romero, Maria, Virmani, Renu, Finn, Aloke V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721792/ https://www.ncbi.nlm.nih.gov/pubmed/29150493 http://dx.doi.org/10.1161/JAHA.117.007244 |
Ejemplares similares
-
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis
por: Valgimigli, Marco, et al.
Publicado: (2014) -
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
por: Natsuaki, Masahiro, et al.
Publicado: (2015) -
Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials
por: Ferko, Nicole, et al.
Publicado: (2016) -
One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries
por: Vlieger, Selina, et al.
Publicado: (2020) -
Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry
por: Gil, Robert J., et al.
Publicado: (2020)